CORCEPT THERAPEUTICS I
54.30
07-11月-24 15:59:58
15 分の遅延
株式
+0.07
+0.13%
本日の幅
53.65 - 55.24
ISIN
N/A
ソース
NASDAQ
-
William Guyer to join Corcept as Chief Development Officer
12 8 2021 17:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
29 7 2021 16:05:03 提供 Nasdaq GlobeNewswire
-
12 7 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
22 6 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
15 6 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
10 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
06 5 2021 16:10:00 提供 Nasdaq GlobeNewswire
-
06 5 2021 16:01:01 提供 Nasdaq GlobeNewswire
-
29 4 2021 16:05:01 提供 Nasdaq GlobeNewswire
-
15 3 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
01 3 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
23 2 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
08 2 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
01 2 2021 16:05:00 提供 Nasdaq GlobeNewswire